C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 265/30 (2006.01) A61K 31/4725 (2006.01) A61K 31/5355 (2006.01) A61K 31/54 (2006.01) A61K 31/553 (2006.01) A61P 7/00 (2006.01) C07D 265/32 (2006.01) C07D 267/10 (2006.01) C07D 279/06 (2006.01) C07D 401/12 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 417/04 (2006.01)
Patent
CA 2745121
The present invention provides a compound of Formula (I) as described herein, or a pharmaceutically acceptable salt or a solvate thereof. The present invention also provides pharmaceutical compositions comprising one or more said com-pounds, and methods for using said compounds for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.
La présente invention porte sur un composé de Formule (I) tel que décrit présentement, ou sur un sel ou un solvate pharmaceutiquement acceptable de celui-ci. La présente invention porte également sur des compositions pharmaceutiques comprenant un ou plusieurs desdits composés, et sur des procédés d'utilisation desdits composés pour le traitement ou la prévention de thromboses, d'embolies, d'une hypercoagulabilité ou de changements fibrotiques.
Chackalamannil Samuel
Chan Tin-Yau
Chelliah Mariappan V.
Clasby Martin C.
Dwyer Michael P.
Mochida Pharmaceutical Co. Ltd.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Morpholinone compounds as factor ixa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Morpholinone compounds as factor ixa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morpholinone compounds as factor ixa inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1755811